Holen Sie sich die Stockscreener-App
2.71
3.83%
0.10
Handel nachbörslich:
2.70
-0.010
-0.37%
Schlusskurs vom Vortag:
$2.61
Offen:
$2.61
24-Stunden-Volumen:
884.55K
Relative Volume:
1.20
Marktkapitalisierung:
$162.28M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-40.33M
KGV:
-1.514
EPS:
-1.79
Netto-Cashflow:
$-39.53M
1W Leistung:
+4.63%
1M Leistung:
-13.42%
6M Leistung:
-31.22%
1J Leistung:
+5.45%
1-Tages-Spanne:
$2.61
$2.84
1-Wochen-Bereich:
$2.54
$2.84
52-Wochen-Spanne:
$2.375
$5.54
Eledon Pharmaceuticals Inc Stock (ELDN) Company Profile
Firmenname
Eledon Pharmaceuticals Inc
Sektor
Branche
Telefon
949-238-8090
Adresse
19800 MACARTHUR BLVD., IRVINE
Vergleichen Sie ELDN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ELDN
Eledon Pharmaceuticals Inc
|
2.71 | 156.29M | 0 | -40.33M | -39.53M | -1.79 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Eledon Pharmaceuticals Inc Stock (ELDN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-18 | Fortgesetzt | H.C. Wainwright | Buy |
| 2025-01-28 | Eingeleitet | Guggenheim | Buy |
| 2022-05-13 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2021-03-23 | Eingeleitet | Cantor Fitzgerald | Overweight |
Eledon Pharmaceuticals Inc Aktie (ELDN) Neueste Nachrichten
why eledon pharmaceuticals inc. is moving today2025 Dividend Review & Free Real-Time Market Sentiment Alerts - Newser
How sentiment analysis helps forecast Eledon Pharmaceuticals Inc.Weekly Stock Recap & Expert Verified Stock Movement Alerts - Newser
Applying sector rotation models to Eledon Pharmaceuticals Inc.July 2025 Summary & Daily Technical Forecast Reports - Newser
Is Eledon Pharmaceuticals Inc. forming a reversal patternMarket Trend Review & Expert-Curated Trade Recommendations - Newser
Understanding Eledon Pharmaceuticals Inc.’s price movementMarket Performance Report & Verified Stock Trade Ideas - Newser
Detecting support and resistance levels for Eledon Pharmaceuticals Inc.July 2025 Institutional & High Accuracy Buy Signal Tips - Newser
Regression analysis insights on Eledon Pharmaceuticals Inc. performanceFed Meeting & Reliable Price Breakout Signals - Newser
Pattern recognition hints at Eledon Pharmaceuticals Inc. upside2025 Fundamental Recap & AI Driven Stock Price Forecasts - Newser
Historical volatility pattern of Eledon Pharmaceuticals Inc. visualizedBuy Signal & High Accuracy Buy Signal Tips - Newser
Using fundamentals and technicals on Eledon Pharmaceuticals Inc.Trade Entry Summary & Precise Buy Zone Identification - Newser
How to monitor Eledon Pharmaceuticals Inc. with trend dashboardsJuly 2025 Snapshot & Reliable Entry Point Trade Alerts - Newser
Volume spikes in Eledon Pharmaceuticals Inc. stock – what they meanJuly 2025 PreEarnings & Fast Gaining Stock Reports - Newser
What the charts say about Eledon Pharmaceuticals Inc. todayTrade Exit Summary & Safe Capital Investment Plans - Newser
Eledon Pharmaceuticals at Cantor Conference: Kidney Transplant Innovations By Investing.com - Investing.com Canada
Can machine learning forecast Eledon Pharmaceuticals Inc. recovery2025 Market Trends & Long-Term Growth Stock Strategies - Newser
Can Eledon Pharmaceuticals Inc. continue delivering strong returnsWeekly Gains Summary & Entry Point Strategy Guides - خودرو بانک
What’s the RSI of Eledon Pharmaceuticals Inc. stockJuly 2025 Analyst Calls & Growth Focused Stock Pick Reports - خودرو بانک
What is Eledon Pharmaceuticals Inc. s debt to equity ratio2025 Key Highlights & Smart Swing Trading Techniques - خودرو بانک
Is Eledon Pharmaceuticals Inc. stock bottoming outJuly 2025 Sentiment & Low Drawdown Momentum Trade Ideas - Newser
Will Eledon Pharmaceuticals Inc. outperform the marketJuly 2025 Opening Moves & Real-Time Market Sentiment Alerts - Newser
HC Wainwright Brokers Boost Earnings Estimates for ELDN - Defense World
Analyzing drawdowns of Eledon Pharmaceuticals Inc. with statistical toolsJuly 2025 Decliners & Fast Entry Momentum Alerts - Newser
Why Eledon Pharmaceuticals Inc. is moving todayDollar Strength & Reliable Breakout Forecasts - Newser
How high can Eledon Pharmaceuticals Inc. stock goRecession Risk & Community Consensus Picks - Newser
Can Eledon Pharmaceuticals Inc. hit a new high this monthJuly 2025 Gainers & Weekly Breakout Opportunity Watchlist - Newser
Backtesting results for Eledon Pharmaceuticals Inc. trading strategies2025 AllTime Highs & Daily Chart Pattern Signals - Newser
Analyzing Eledon Pharmaceuticals Inc. with multi timeframe charts2025 Short Interest & Risk Adjusted Buy and Sell Alerts - Newser
Is a relief rally coming for Eledon Pharmaceuticals Inc. holders2025 Market Outlook & Low Risk Profit Maximizing Plans - Newser
Tools to assess Eledon Pharmaceuticals Inc.’s risk profileTrade Analysis Summary & Safe Entry Trade Reports - Newser
Eledon Pharmaceuticals Inc. stock outlook for YEARQuarterly Portfolio Review & AI Driven Price Predictions - Newser
Eledon Pharmaceuticals Inc. stock trendline breakdownOptions Play & Real-Time Market Sentiment Alerts - Newser
Sector ETF performance correlation with Eledon Pharmaceuticals Inc.Weekly Gains Report & Consistent Profit Alerts - Newser
Eledon Pharmaceuticals’ (ELDN) “Buy” Rating Reaffirmed at HC Wainwright - Defense World
Risk vs reward if holding onto Eledon Pharmaceuticals Inc.Weekly Trade Review & Fast Moving Stock Trade Plans - Newser
News impact scoring models applied to Eledon Pharmaceuticals Inc.Portfolio Update Summary & Stepwise Entry/Exit Trade Alerts - Newser
How to read the order book for Eledon Pharmaceuticals Inc.2025 Retail Activity & Free Accurate Trade Setup Notifications - Newser
Finanzdaten der Eledon Pharmaceuticals Inc-Aktie (ELDN)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):